Barbro Linderholm

6.2k citations
74 papers · 2.3k indexed · h-index 25
Topics
Breast Cancer Treatment Studies (35 papers)HER2/EGFR in Cancer Research (18 papers)Angiogenesis and VEGF in Cancer (17 papers)

In The Last Decade

Barbro Linderholm

72 papers receiving 2.3k citations

Peers

Barbro Linderholm
Comparison fields: 5 of 96
  • Oncology 1.3k
  • Molecular Biology 1.2k
  • Cancer Research 1.0k
  • Genetics 334
  • Pulmonary and Respiratory Medicine 329
Replace Hiroyoshi Doihara with:
Hiroyoshi Doihara Japan
Per Malmström Sweden
Melanie Royce United States
Alberto Bottini Italy
Akbar Shah Hussainy Pakistan
Ahmed Alhujaily Saudi Arabia
Oleg Gluz Germany
Hiroshi Sonoo Japan
Sherry X. Yang United States
Zhen‐Zhou Shen China
Barbro Linderholm relative to Hiroyoshi Doihara Japan Hiroyoshi Doihara's profile →
Citations per field
00.5×1.5×
Hiroyoshi Doihara · 1×
Citations per year

Countries citing papers authored by Barbro Linderholm

Since Specialization
Citations

This map shows the geographic impact of Barbro Linderholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbro Linderholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbro Linderholm more than expected).

Fields of papers citing papers by Barbro Linderholm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbro Linderholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbro Linderholm. The network helps show where Barbro Linderholm may publish in the future.

Co-authorship network of co-authors of Barbro Linderholm

This figure shows the co-authorship network connecting the top 25 collaborators of Barbro Linderholm. A scholar is included among the top collaborators of Barbro Linderholm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbro Linderholm. Barbro Linderholm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 1
4 2
5 1
6 0
7 2
8 5
9 3
10 5
11 9
12 22
13 8
14 3
15 60
16 10
17 36
18 84
19 43
20 41

About Barbro Linderholm

Barbro Linderholm is a scholar working on Cancer Research, Oncology and Genetics, having authored 74 papers that have together received 2.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (35 papers), HER2/EGFR in Cancer Research (18 papers) and Angiogenesis and VEGF in Cancer (17 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.3k citations) and Molecular Biology (1.2k citations). Barbro Linderholm has collaborated with scholars based in Sweden, United Kingdom and Belgium. Frequent co-authors include Kjell Grankvist, Björn Tavelin, Roger Henriksson, Rolf Lewensohn, Jonas Bergh, Göran Elmberger, Lambert Skoog, Janne Lehtiö, Henrik Hellborg and Birgitta Lindh. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026